Yahoo Web Search

Search results

1. AbbVie Inc.

   NYSE: ABBV

   170.46

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +1.04 (+0.61%)

   At close: Mon. Jun 10, 2024 4:00 PM EDT · Delayed Quote (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	169.00
     High	170.75
     Low	167.69

   • Mkt Cap	301.01B
     P/E (TTM)	50.73
     Div & Yield	6.20 & 3.64%

   • Prev. Close	169.42
     52 Wk. Low	130.96
     52 Wk. High	182.89

   More about ABBV

   What analysts are saying

   Morningstar Published April 26 · AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and... Read more

   Top stories

   • ABBV
     +0.61%

   AbbVie (ABBV) Laps the Stock Market: Here's Why

   Yahoo Finance · 9 hours ago

   

   • PFE
     -1.78%
   • ABBV
     +0.61%
   • MRK
     +0.63%

   AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal

   Yahoo Finance · 4 days ago

   

   • PFE
     -1.78%
   • ABBV
     +0.61%
   • JNJ
     +0.03%

   AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug

   Yahoo Finance · 5 days ago

   

   Related stocks

   • ABT
     Abbott Laboratories
     ABT
     107.49
     -0.08%
   • BMY
     Bristol-Myers Squibb Company
     BMY
     42.57
     +2.63%
   • JNJ
     Johnson & Johnson
     JNJ
     147.13
     +0.03%
   • GILD
     Gilead Sciences, Inc.
     GILD
     65.25
     +0.85%
   • MRK
     Merck & Co., Inc.
     MRK
     131.49
     +0.63%

   More on Yahoo Finance

2. seekingalpha.com › symbol › ABBVAbbVie Inc. (ABBV) Stock Price, Quote, News & Analysis

   seekingalpha.com › symbol › ABBV

   • Cached

   4 days ago · A high-level overview of AbbVie Inc. (ABBV) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

   • Company name: Amgen Inc.
   • Industry: Biotechnology

   • Employees: 26,700
   • Market Cap: 146.72B

3. www.cnn.com › markets › stocksABBV Stock Quote Price and Forecast | CNN

   www.cnn.com › markets › stocks

   • Cached

   4 days ago · View AbbVie, Inc. ABBV stock quote prices, financial information, real-time forecasts, and company news from CNN.

4. stockanalysis.com › stocks › abbvAbbVie Inc. (ABBV) Stock Price, Quote & News - Stock Analysis

   stockanalysis.com › stocks › abbv

   • Cached

   4 days ago · Get the latest information on AbbVie Inc. (ABBV), a global biopharmaceutical company, including its stock price, earnings, dividends, news, and analysis. See how AbbVie's products, such as Humira, Skyrizi, and Imbruvica, are performing in the market and how they are impacting its financial performance.

   • 
   • 
   • 
   • 

5. www.marketbeat.com › stocks › NYSEAbbVie (ABBV) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com › stocks › NYSE

   • Cached

   4 days ago · Should You Buy or Sell AbbVie Stock? Get The Latest ABBV Stock Analysis, Price Target, Dividend Info, Headlines, and Short Interest at MarketBeat.

   • 4.8/5

   • Employees: 50K

6. markets.businessinsider.com › news › stocksAnalyst Scoreboard: 6 Ratings For AbbVie | Markets Insider

   markets.businessinsider.com › news › stocks

   • Cached

   6 days ago · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $189.5, along with a high estimate of $200.00 and a low estimate of $180.00. This ...

7. stockanalysis.com › stocks › abbvAbbVie Inc. (ABBV) Stock Forecast & Price Targets - Stock ...

   stockanalysis.com › stocks › abbv

   • Cached

   5 days ago · Stock Price Forecast. The 11 analysts with 12-month price forecasts for AbbVie stock have an average target of 183.18, with a low estimate of 150 and a high estimate of 200. The average target predicts an increase of 8.67% from the current stock price of 168.57.

8. People also ask

   What is the consensus rating for AbbVie stock?

   • AbbVie has received a consensus rating of Hold. The company's average rating score is 2.36, and is based on 6 buy ratings, 7 hold ratings, and 1 sell rating. According to analysts' consensus price target of $158.78, AbbVie has a forecasted downside of 1.8% from its current price of $161.61.

   AbbVie - ABBV Stock Forecast, Price & News - MarketBeat

   www.marketbeat.com/stocks/NYSE/ABBV/

   See all results for this question

   What is the history of AbbVie Inc. (ABBV) stock?

   • AbbVie has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. AbbVie Inc. is a US-based biopharma company with global operations. The company originated as the bio-pharma segment of Abbott Laboratories and was spun off in late 2012.

   AbbVie - ABBV Stock Forecast, Price & News - MarketBeat

   www.marketbeat.com/stocks/NYSE/ABBV/

   See all results for this question

   What is Abbvie Inc.'s stock symbol?

   • AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

   AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You ...

   finance.yahoo.com/news/abbvie-inc-abbv-attracting-investor-140002388.html

   See all results for this question

9. simplywall.st › stocks › usAbbVie NYSE:ABBV Stock Report - Simply Wall St

   simplywall.st › stocks › us

   • Cached

   2 days ago · Research AbbVie's (NYSE:ABBV) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.